• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 miR-632 是喉鳞状细胞癌诊断和预后的潜在标志物。

Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.

机构信息

Department of Ear-Nose-Throat, Dongying People's Hospital, Dongying, China.

Department of Oncology, Dongying People's Hospital, Dongying, China.

出版信息

Acta Otolaryngol. 2020 May;140(5):418-421. doi: 10.1080/00016489.2020.1717610. Epub 2020 Feb 18.

DOI:10.1080/00016489.2020.1717610
PMID:32068453
Abstract

It has been demonstrated that miRNAs play critical roles in the tumorigenesis and progression of various tumors. The purpose of this research was to determine the serum miR-632 levels in patients with laryngeal squamous cell carcinoma (LSCC) and to investigate its diagnostic and prognostic value. We detected serum miR-632 levels in 162 LSCC patients and 42 healthy volunteers. The ROC curve was carried out to determine diagnostic accuracy. We observed that serum miR-632 levels were upregulated in LSCC patients compared with healthy volunteers ( < .01). Subsequent results from ROC indicated that high sensitivity and specificity of serum miR-632 for diagnosing LSCC (area under the curve 0.8828). In addition, it was found that high expressions of serum miR-632 were significantly associated with advanced N stage ( = .020), histological grade ( = .001), and TNM stage ( = .014). Furthermore, patients with higher serum miR-632 expression had a shorter OS and DFS time than those with lower serum miR-632 levels. Our data revealed that serum miR-632 may be a potential noninvasive biomarker which may become a potential diagnostic and prognostic biomarker for LSCC patients.

摘要

已经证实,miRNAs 在各种肿瘤的发生和发展中起着关键作用。本研究旨在测定喉鳞状细胞癌(LSCC)患者血清 miR-632 水平,并探讨其诊断和预后价值。我们检测了 162 例 LSCC 患者和 42 例健康志愿者的血清 miR-632 水平。绘制 ROC 曲线以确定诊断准确性。我们观察到 LSCC 患者的血清 miR-632 水平较健康志愿者升高( < .01)。ROC 的后续结果表明,血清 miR-632 对 LSCC 的诊断具有较高的敏感性和特异性(曲线下面积 0.8828)。此外,还发现血清 miR-632 的高表达与较晚的 N 分期( = .020)、组织学分级( = .001)和 TNM 分期( = .014)显著相关。此外,血清 miR-632 表达较高的患者的 OS 和 DFS 时间短于血清 miR-632 水平较低的患者。我们的数据表明,血清 miR-632 可能是一种潜在的非侵入性生物标志物,可能成为 LSCC 患者潜在的诊断和预后生物标志物。

相似文献

1
Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.血清 miR-632 是喉鳞状细胞癌诊断和预后的潜在标志物。
Acta Otolaryngol. 2020 May;140(5):418-421. doi: 10.1080/00016489.2020.1717610. Epub 2020 Feb 18.
2
Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.联合检测血清外泌体miR-21和HOTAIR作为喉鳞状细胞癌的诊断和预后生物标志物
Med Oncol. 2014 Sep;31(9):148. doi: 10.1007/s12032-014-0148-8. Epub 2014 Aug 7.
3
Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).喉鳞状细胞癌(LSCC)患者血清中选定 miRNA 的表达。
Diagn Pathol. 2019 May 28;14(1):49. doi: 10.1186/s13000-019-0823-3.
4
The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.微小RNA-155在人喉鳞状细胞癌血浆和组织中的表达具有相关性。
Yonsei Med J. 2016 Mar;57(2):298-305. doi: 10.3349/ymj.2016.57.2.298.
5
Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.血清高迁移率族蛋白B1在喉鳞状细胞癌诊断及预后中的临床价值
Med Oncol. 2014 Dec;31(12):316. doi: 10.1007/s12032-014-0316-x. Epub 2014 Nov 6.
6
miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma.miR-21、miR-106b和miR-375作为喉鳞状细胞癌新的潜在生物标志物。
Curr Pharm Biotechnol. 2014;15(5):503-8. doi: 10.2174/1389201015666140519110616.
7
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma.鉴定和生物信息学分析用于早期检测喉鳞癌的血清 miRNA 特征。
J Transl Med. 2024 Jul 10;22(1):647. doi: 10.1186/s12967-024-05385-3.
8
Droplet digital PCR and qRT-PCR to detect circulating miR-21 in laryngeal squamous cell carcinoma and pre-malignant laryngeal lesions.采用液滴数字PCR和定量逆转录PCR检测喉鳞状细胞癌及癌前喉病变中循环miR-21。
Acta Otolaryngol. 2016 Sep;136(9):923-32. doi: 10.3109/00016489.2016.1165862. Epub 2016 Apr 12.
9
Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.喉鳞状细胞癌患者血浆中 microRNAs 的差异表达:喉鳞状细胞癌的潜在早期检测标志物。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1499-506. doi: 10.1007/s00432-013-1469-2. Epub 2013 Jul 2.
10
Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.纤维蛋白原、纤维蛋白降解产物和淋巴细胞/单核细胞比值对喉鳞状细胞癌患者的诊断和预后价值。
Ear Nose Throat J. 2024 May;103(5):NP278-NP288. doi: 10.1177/01455613211048970. Epub 2021 Oct 21.

引用本文的文献

1
Laryngeal Cancer in the Modern Era: Evolving Trends in Diagnosis, Treatment, and Survival Outcomes.现代喉癌:诊断、治疗及生存结果的演变趋势
J Clin Med. 2025 May 12;14(10):3367. doi: 10.3390/jcm14103367.
2
A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma.关于微小RNA作为喉癌预后生物标志物的批判性综述
Int J Mol Sci. 2024 Dec 16;25(24):13468. doi: 10.3390/ijms252413468.
3
Liquid biopsy in cancer current: status, challenges and future prospects.癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
4
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.微小RNA在喉癌患者中的诊断和预后价值:一项系统评价
Noncoding RNA. 2023 Jan 19;9(1):9. doi: 10.3390/ncrna9010009.
5
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.喉癌分子生物标志物概述:探寻一个老问题的新答案
Cancers (Basel). 2022 Mar 28;14(7):1716. doi: 10.3390/cancers14071716.
6
Aberrant expression of five miRNAs in papillary thyroid carcinomas.五种微小 RNA 在甲状腺乳头状癌中的异常表达。
J Clin Lab Anal. 2021 Sep;35(9):e23907. doi: 10.1002/jcla.23907. Epub 2021 Jul 16.